Tadao Tsubokura
Comptroller/Controller/Auditor at SAWAI GROUP HOLDINGS CO., LTD.
Network origin in Tadao Tsubokura first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Sawai Pharmaceutical Co., Ltd.
 Sawai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. It operates through the Japan and United States segments. The Japan segment sells manufactured pharmaceuticals to domestic sales companies, wholesale stores and other pharmaceutical manufacturers, as well as directly to medical institutions. The United States segment comprises of holding companies that manages subsidiaries and sell manufactured pharmaceuticals to wholesale stores in the United States. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan.
14
| Subsidiary | Pharmaceuticals: Major | 14 |
| Public Company | Pharmaceuticals: Major | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Tadao Tsubokura via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Medisa Shinyaku, Inc.
 Medisa Shinyaku, Inc. Pharmaceuticals: GenericHealth Technology Part of SAWAI GROUP HOLDINGS Co., Ltd., Medisa Shinyaku, Inc. is a pharmaceutical company based in Osaka, Japan. The company's description is in Japanese, but it appears to be a subsidiary of Sawai Pharmaceutical Co., Ltd. and is involved in the manufacture and sale of pharmaceuticals. The company has been updating its corporate information and has made several announcements regarding its business activities. | Pharmaceuticals: Generic | Director/Board Member President President Director/Board Member Director/Board Member | |
Upsher-Smith Laboratories LLC
 Upsher-Smith Laboratories LLC Pharmaceuticals: MajorHealth Technology Upsher-Smith Laboratories, Inc. manufactures generic pharmaceuticals. It serves the pharmacists, physicians, and patients. The firm offers manufacturing, distribution, sales, and marketing services. The company was founded by Frederick Alfred Upsher Smith in 1919 and is headquartered in Maple Grove, MN. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer Chief Administrative Officer | |
| Kaken Shoyaku KK | President Director/Board Member | ||
Sawai America LLC
 Sawai America LLC Pharmaceuticals: MajorHealth Technology Sawai America, Inc. operates as a holding company with interests in generic drug manufacturing. The company is headquartered in MN. | Pharmaceuticals: Major | President | |
| Osaka City University | College/University | Corporate Officer/Principal | |
| NIPPON PAINT HOLDINGS CO., LTD. | Industrial Specialties | Director/Board Member | |
Teijin Frontier Co., Ltd.
 Teijin Frontier Co., Ltd. Wholesale DistributorsDistribution Services Teijin Frontier Co., Ltd. distributes, imports, exports clothing products, industrial materials, plastics, films, packaging and construction use materials. The company was founded on October 1, 2012 and is headquartered in Osaka, Japan. | Wholesale Distributors | Director/Board Member | |
| ATSUGI CO., LTD. | Apparel/Footwear | Director/Board Member | |
Astellas Pharma Technologies, Inc.
 Astellas Pharma Technologies, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Technologies, Inc. manufactures pharmaceutical services. The company is headquartered in Norman, OK. | Pharmaceuticals: Major | Chairman | |
| Takasaki University of Health & Welfare | Corporate Officer/Principal | ||
Sumitomo Mitsui Banking Corp.
 Sumitomo Mitsui Banking Corp. Major BanksFinance Sumitomo Mitsui Banking Corp. engages in the provision of financial services centered on banking. It operates through the following business segments: Wholesale, Retail, International, Market Sales, and Headquarters Management. The Wholesale segment covers business for customers of large and medium-sized companies in Japan. The Retail segment handles business for domestic individuals and SME customers. The International segment comprises of business for overseas Japanese and non-Japanese companies. The Market Sales segment corresponds to financial market business. The Headquarters Management segment includes all other businesses not covered by other segments. The company was founded in April 2001 and is headquartered in Tokyo, Japan. | Major Banks | Corporate Officer/Principal | |
| ASTELLAS PHARMA INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
C&O Pharmaceutical Technology (Holdings) Ltd.
 C&O Pharmaceutical Technology (Holdings) Ltd. Pharmaceuticals: MajorHealth Technology C&O Pharmaceutical Technology (Holdings) Ltd. manufactures and distributes pharmaceutical products. It offers anti-infection and gastrointestinal drugs, drugs for ageing adults, and specialized drugs. The firm's products are used for various indications, such as skin soft tissues infections, analgesic and antipyretic, indigestion or gastro esophageal reflux disorder, respiratory tract infections, sinusitis, hypertension and migraine. The company was founded by Lai Chi Ma and Bin Gao in 2003 and is headquartered in Hong Kong. | Pharmaceuticals: Major | Director/Board Member | |
| Kyoto University | College/University | Undergraduate Degree |
Statistics
International
| Japan | 13 |
| United States | 4 |
| Hong Kong | 2 |
Sectoral
| Health Technology | 9 |
| Consumer Services | 3 |
| Process Industries | 2 |
| Distribution Services | 2 |
| Consumer Non-Durables | 2 |
Operational
| Director/Board Member | 30 |
| Corporate Officer/Principal | 16 |
| President | 8 |
| Chairman | 5 |
| Independent Dir/Board Member | 5 |
Most connected contacts
- Stock Market
- Insiders
- Tadao Tsubokura
- Company connections